He Wang

NO.71 Hedi Road Qingxiu Square
Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Correction: Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides.

Correction: Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides.

Journal: Journal of translational medicine

Published: August 28, 2026

Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy.

Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy.

Journal: BMC biotechnology

Published: May 13, 2026

Anti-CD20 and -PD-1 antibody effects on proliferation, apoptosis and cell cycle of endometrial cancer cells.

Anti-CD20 and -PD-1 antibody effects on proliferation, apoptosis and cell cycle of endometrial cancer cells.

Journal: Oncology letters

Published: January 21, 2026

Niraparib treatment patterns and outcomes in first-line maintenance therapy for ovarian cancer: The RENI-1 study.

Niraparib treatment patterns and outcomes in first-line maintenance therapy for ovarian cancer: The RENI-1 study.

Journal: Chinese medical journal

Published: December 23, 2025

Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides.

Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides.

Journal: Journal of translational medicine

Published: August 03, 2025

Corrigendum to 'Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial' [Journal of the National Cancer Center 4 (2024) 135-141].

Corrigendum to 'Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial' [Journal of the National Cancer Center 4 (2024) 135-141].

Journal: Journal of the National Cancer Center

Published: March 05, 2025

Identification and validation of NEIL2 as a prognostic biomarker and potential therapeutic target in cervical cancer.

Identification and validation of NEIL2 as a prognostic biomarker and potential therapeutic target in cervical cancer.

Journal: Discover oncology

Published: November 30, 2024

The mechanism of ECT1/E6E7 cervical intraepithelial neoplasia cells regulated by Acinetobacter lwoffii through circ-LDHA/HMGB1.

The mechanism of ECT1/E6E7 cervical intraepithelial neoplasia cells regulated by Acinetobacter lwoffii through circ-LDHA/HMGB1.

Journal: BMC microbiology

Published: November 07, 2024

The causal relationship between anti-CD20 antibodies and endometrial cancer: a Mendelian randomization study.

The causal relationship between anti-CD20 antibodies and endometrial cancer: a Mendelian randomization study.

Journal: Discover oncology

Published: February 15, 2024

Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial.

Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial.

Journal: Journal of the National Cancer Center

Published: December 07, 2023

Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis.

Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: February 12, 2023

The risk and latency evaluation of secondary primary malignancies of cervical cancer patients who received radiotherapy: A study based on the SEER database.

The risk and latency evaluation of secondary primary malignancies of cervical cancer patients who received radiotherapy: A study based on the SEER database.

Journal: Frontiers in oncology

Published: October 14, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026